Cargando…
Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer’s Disease Rat Model: A Proof-of-Concept Study
An early and persistent sign of Alzheimer’s disease (AD) is glucose hypometabolism, which can be evaluated by positron emission tomography (PET) with (18)F-2-fluoro-2-deoxy-D-glucose ([(18)F]FDG). Cannabidiol has demonstrated neuroprotective and anti-inflammatory properties but has not been evaluate...
Autores principales: | de Paula Faria, Daniele, Estessi de Souza, Larissa, Duran, Fabio Luis de Souza, Buchpiguel, Carlos Alberto, Britto, Luiz Roberto, Crippa, José Alexandre de Souza, Filho, Geraldo Busatto, Real, Caroline Cristiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835532/ https://www.ncbi.nlm.nih.gov/pubmed/35163003 http://dx.doi.org/10.3390/ijms23031076 |
Ejemplares similares
-
(11)C-PK11195 plasma metabolization has the same rate in multiple sclerosis patients and healthy controls: a cross-sectional study
por: de Souza, Aline Morais, et al.
Publicado: (2021) -
Potential of [(11)C](R)-PK11195 PET Imaging for Evaluating Tumor Inflammation: A Murine Mammary Tumor Model
por: de Souza, Aline Morais, et al.
Publicado: (2022) -
Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study
por: MACHADO-VIEIRA, RODRIGO, et al.
Publicado: (2014) -
Cannabidiol for the treatment of refractory epilepsy in children: a critical review of the literature
por: Moreira, Gabriela Araujo, et al.
Publicado: (2022) -
Selecting the most relevant brain regions to discriminate Alzheimer's disease patients from healthy controls using multiple kernel learning: A comparison across functional and structural imaging modalities and atlases
por: Rondina, Jane Maryam, et al.
Publicado: (2017)